Alcon Inc. (ALC): Price and Financial Metrics


Alcon Inc. (ALC)

Today's Latest Price: $63.79 USD

0.61 (0.97%)

Updated Nov 27 5:00pm

Add ALC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

ALC Stock Summary

  • Alcon Inc's market capitalization of $31,146,288,477 is ahead of 92.97% of US-listed equities.
  • ALC's went public 1.64 years ago, making it older than merely 3.13% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 1,858.97%, Alcon Inc's debt growth rate surpasses 98.75% of about US stocks.
  • Stocks that are quantitatively similar to ALC, based on their financial statements, market capitalization, and price volatility, are PPG, CHT, CMI, RMD, and CERN.
  • Visit ALC's SEC page to see the company's official filings. To visit the company's web site, go to www.alcon.com.

ALC Stock Price Chart Interactive Chart >

Price chart for ALC

ALC Price/Volume Stats

Current price $63.79 52-week high $68.11
Prev. close $63.18 52-week low $39.37
Day low $63.16 Volume 199,790
Day high $63.95 Avg. volume 1,301,385
50-day MA $60.65 Dividend yield N/A
200-day MA $58.06 Market Cap 31.14B

Alcon Inc. (ALC) Company Bio


Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

ALC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$63.79$0.23 -100%

We started the process of determining a valid price forecast for Alcon Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Alcon Inc ranked in the 0th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Alcon Inc ended up being:

  • The company's compound free cash flow growth rate over the past 1.28 years comes in at -0.46%; that's greater than merely 2.7% of US stocks we're applying DCF forecasting to.
  • Alcon Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -1.94. This coverage rate is greater than that of just 18.1% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Alcon Inc experienced a tax rate of about 309% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 98.63% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-100%
1%-100%
2%-100%
3%-100%
4%-100%
5%-100%

AGHC, AMRN, ATRS, MOR, and PACB can be thought of as valuation peers to ALC, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


ALC Latest News Stream


Event/Time News Detail
Loading, please wait...

ALC Latest Social Stream


Loading social stream, please wait...

View Full ALC Social Stream

Latest ALC News From Around the Web

Below are the latest news stories about Alcon Inc that investors may wish to consider to help them evaluate ALC as an investment opportunity.

Alcon (ALC) Presents At Morgan Stanley Annual Global Healthcare Conference - Slideshow

The following slide deck was published by Alcon Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 18, 2020

Alcon Inc. (ALC) CEO David Endicott on Q2 2020 Results - Earnings Call Transcript

Alcon Inc. (ALC) Q2 2020 Results Conference Call August 19, 2020 08:00 AM ET Company Participants Karen King - SVP, Corporate Affairs David Endicott - CEO Tim Stonesifer - CFO Conference Call Participants Veronika Dubajova - Goldman Sachs Matt Miksic - Credit Suisse Jeff Johnson - Baird Steve Willoughby -...

SA Transcripts on Seeking Alpha | August 19, 2020

Read More 'ALC' Stories Here

ALC Price Returns

1-mo 12.23%
3-mo 11.25%
6-mo 0.81%
1-year 15.37%
3-year N/A
5-year N/A
YTD 12.76%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7432 seconds.